Centro Internacional de Entrenamiento e Investigaciones Médicas   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Santiago de Cali Colombia (1994)

Organization Overview

First Clinical Trial
2000
NCT00378625
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Centro Internacional de Entrenamiento e Investigaciones Médicas | Centro Internacional de Entrenamiento e Investigación Médica

Active Ingredients

Drugs in Phase 4 Trials (1)

miltefosine (impavido) (2 trials)

Drugs in Phase 3 Trials (4)

artesunate (1 trial)

meglumine (1 trial)

methylglucamine antimoniate (1 trial)

pentoxifylline (trental) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leishmaniasis (Phase 4)

Leishmaniasis, Cutaneous (Phase 4)

Malaria (Phase 3)

Malaria, Falciparum (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5